James R. Swartling is an author at Eli Lilly (United States) specializing in medicine, bioanalysis, and engineering.
Top concepts
MedicineBioanalysisEngineeringBiochemistryAntibody EngineeringBacteriologyBiosynthesisCell BiologyCell CultureMicrobiology
Publications per year
1994–2017
6
6
Novel Lipoglycopeptides as Inhibitors of Bacterial Signal Peptidase I
Palaniappan Kulanthaivel, A J Kreuzman, Mark A. Strege et al. · Journal of Biological Chemistry · 2004 · 102 citations · Full text
A J Kreuzman, Roland Hodges, James R. Swartling et al. · Journal of Industrial Microbiology & Biotechnology · 2000 · 26 citations · Full text
Rows per page
1–5 of 6